Lophora is funded by BII (Novo Nordisk Foundation), Innovation Fund Denmark, Export and Investment Fund of Denmark (EIFO), family offices and experienced biotech investors such as Don deBethizy (USA) and Tim Haines (UK).

Lophora is currently (Winter 2023/24) preparing a capital increase to raise US$ 5-8 M for completion of Phase I for LPH-5 and advance additional pipeline programs.